Surveillance for Hepatocellular Carcinoma after Autologous Stem Cell Transplantation in Cirrhosis
Authors:
Open Access
- 1 July 2012
- journal article
- Vol. 4 (3) , 145-149
Abstract
During the resent years there has been interest in using bone marrow stem cells to treat liver cirrhosis. However, there is a potential concern for malignant transformation after stem cell therapy. The aim of this study was to evaluate the development of hepatocellular carcinoma (HCC) after autologous bone marrow stem cell transplantation for liver cirrhosis. All the patients who underwent autologous stem cell transplantation for liver cirrhosis between 2005 and 2011 at our center were enrolled. Cellular infusion was made through peripheral vein, portal vein, or hepatic artery.The patients were invited to undergo screening for hepatocellular carcinoma. The screening was made with ultrasonography and alpha-feto protein (AFP) measurement. Thirty two patients (18 males) were included in the study. Mean age of patients was 45.7 years. Fifteen patients (47%) received mesenchymal stem cell (MSC), 9 (28%) received bone marrow mononuclear cells, 5 (16%) were given CD 133-positive bone marrow cells, and 3 (9%) patients received CD 34-positive bone marrow cells. Mean duration of follow up was 20.5months. Mean serum level of AFP was 2.8 ng/ml at baseline and 3.4ng/ml at the end of follow up (p= 0.3). One patient was found to have hepatocellular carcinoma three months after infusion of bone marrow mononuclear cells. The incidence rate for HCC was 1.8 cases per 100 person-years in this study. Autologous bone marrow stem cell infusion does not appear to increase the risk of hepatocellular carcinoma. The incidence rate of HCC in this study is comparable or even less than the reported rates of HCC in cohort studies of cirrhotic patients.Keywords
This publication has 25 references indexed in Scilit:
- Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver CirrhosisAmerican Journal of Gastroenterology, 2008
- Long‐term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver diseaseCell Proliferation, 2007
- Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosisWorld Journal of Gastroenterology, 2007
- Characterization and Clinical Application of Human CD34 + Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating FactorStem Cells, 2006
- Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in ratsWorld Journal of Gastroenterology, 2005
- Transplantation of Bone Marrow Cells Reduces Ccl4–Induced Liver Fibrosis in MiceHepatology, 2004
- Transplanted bone marrow regenerates liver by cell fusionNature, 2003
- Cell fusion is the principal source of bone-marrow-derived hepatocytesNature, 2003
- Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem CellsNew England Journal of Medicine, 2002
- Liver from bone marrow in humansHepatology, 2000